He’s issued a terrifying new warning that Americans need to hear in 2026.‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎ ‎
‎ ‎ ‎ ‎ ‎ ‎ ‎



<[link removed]>

August 16


 



RFK Jr’s FINAL Warning [Seniors Most At Risk?]

Watch Now →
<[link removed]>

 






For years liberals have called RFK Jr a QUACK… an ALARMIST… and a CONSPIRACY
THEORIST.

But now it appears HE WAS RIGHT about a COVID lab leak…

He was RIGHT about microplastics…

And he was RIGHT about FDA corruption.

Now, he’s issued a terrifying new warning
<[link removed]>
that Americans need to hear in 2026.


<[link removed]>
Millions are in the crosshairs…

And if you were born before Jan 1st, 1965, THIS
<[link removed]>
affects you most of all.

Get the full facts here
<[link removed]>
.

P.S. Liberals will call THIS
<[link removed]>
crazy too, until they seethe data
<[link removed]>
. Learn why RFK Jr is warning Americans about this emerging health crisis
before it’s too late. Watchthis video
<[link removed]>
now.
 

 





Three Stories That Could Move Markets (Ad)
Must-See: Trump’s Little-Known Plan to Save Social Security
<[link removed]>
InvestorPlace Media

Learn More →
<[link removed]>


Uncle Sam’s Portfolio Is Up 26x on the S&P 500
<[link removed]>
Weiss Ratings

Learn More →
<[link removed]>


Investing Legend Put Half His Money in This One Stock
<[link removed]>
Stansberry Research

Here’s the Ticker →
<[link removed]>








CONNOR'S HEALTH NOTES

The Largest Modifiable Risk Factor Is a Sense

Connor Hill · InsightfulWord · August 15, 2026

Among the modifiable risk factors for dementia identified in the standing
Lancet Commission on dementia prevention, intervention and care, one carries a
larger estimated population effect than almost any other, and it is not diet,
not exercise, and not any supplement. It is hearing loss in midlife.

That finding has been in the literature for years and has produced almost no
change in behavior, for a reason that is worth examining rather than deploring.
Hearing loss does not present as a health problem. It presents as other people
mumbling.

The mechanism proposed to explain the association is not mysterious. Impaired
hearing reduces the quality of the signal reaching the brain, increases the
cognitive effort required to decode speech, and — the part that probably
matters most — progressively removes a person from the conversations that
constitute their social life. Each of those is a plausible route to accelerated
cognitive decline, and they operate together over decades.

The association alone would not justify much. What changes the picture is that
the question was put to a randomized trial. The ACHIEVE study, published inThe
Lancet in 2023, randomized nearly a thousand older adults with untreated
hearing loss to either a hearing intervention — hearing aids and audiological
support — or a health education control, and followed cognition for three years.

The headline result was negative in the overall population, and honest
reporting has to start there: across all participants, the hearing intervention
did not significantly slow cognitive decline compared with control. In a
prespecified subgroup, however, the picture differed. Among participants at
elevated risk of cognitive decline, drawn from an existing cardiovascular
cohort with more risk factors and faster baseline decline, the hearing
intervention slowed three-year cognitive decline by approximately half relative
to control.

A prespecified subgroup effect in a null trial is exactly the kind of finding
that deserves both attention and caution, and secondary analyses published
since have examined it directly. The reasonable reading is not that hearing
aids prevent dementia. It is that in people already on a declining trajectory,
restoring auditory input appears to slow it, and that in healthier older adults
declining slowly to begin with, three years was not long enough to detect
anything.

What follows is what the evidence supports, what it does not, and why an
intervention this well studied reaches so few of the people it applies to.

Why the Delay Is Measured in Years

The interval between the onset of noticeable hearing difficulty and the
acquisition of a hearing aid is conventionally described in the audiology
literature in years rather than months, and the reasons are behavioral rather
than clinical.

Hearing declines gradually and asymmetrically across frequencies. The first
losses are typically in the higher frequencies that carry consonants — the
sounds that distinguish one word from another — while the lower frequencies
carrying volume remain intact. The subjective experience is therefore not
quietness. It is that speech has become indistinct while remaining perfectly
loud, which produces the near-universal report that everyone has started
mumbling.

Because the deficit is attributed to the speaker rather than the listener, it
does not register as a personal health issue at all. And because the decline is
slow, there is no moment at which anything changed, which is the condition
under which humans are worst at noticing.

The social consequences arrive before the medical ones. Restaurants become
unpleasant. Group conversations become exhausting to follow. Telephone calls
get shorter. The rational response to each of these is mild avoidance, and mild
avoidance compounds into a materially smaller social world over a decade —
which is itself among the risk factors the same Lancet Commission identifies.


📈 Number of the Day

About half

The reduction in three-year cognitive decline seen with hearing intervention
among participants at elevated risk of decline in the ACHIEVE randomized trial
— against no significant effect across the trial population as a whole. Source:
The Lancet, ACHIEVE multicentre randomised controlled trial, 2023, and
subsequent secondary analyses.


Support or oppose: should hearing be tested at every annual visit past sixty?

Hearing loss is common, gradual, easy to test for, and linked in randomized
evidence to the pace of cognitive decline in higher-risk adults. Supporters
argue a brief screening at annual visits would catch a condition people
reliably fail to self-report, and that the intervention is safe and now widely
available. Opponents note that the trial's overall result was null, that
universal screening in a low-risk population has an unimpressive record
generally, and that a test without an accessible treatment pathway generates
frustration rather than benefit. Should hearing screening be routine after
sixty?Hit reply — one line is enough.


What the Evidence Does and Does Not Support

Precision here matters more than usual, because this is a subject on which
overstatement is common in both directions.

What the randomized evidence supports: in older adults with untreated hearing
loss who are already at elevated risk of cognitive decline, providing hearing
aids and audiological support slowed measured cognitive decline over three
years relative to a control receiving health education. That is a real result
from a well-conducted multicentre trial with a prespecified analysis.

What it does not support: that hearing aids prevent dementia, that they
improve cognition in healthy older adults, or that the effect in the
higher-risk group will necessarily persist beyond the trial period. The overall
trial result was null, and a subgroup finding — even a prespecified one — is a
hypothesis strengthened rather than a conclusion established.

What sits alongside it: the observational literature linking hearing loss to
later cognitive outcomes is large and consistent, and consistency across many
cohorts is meaningful even though observational data cannot establish
direction. Reverse causation is a genuine concern here, since early
neurodegeneration can itself impair the central processing of sound.

The honest summary is that this is one of the better-evidenced modifiable
factors in an area where the evidence is generally poor, and that its strongest
claim is on people who already have hearing loss rather than on the general
population. That is a narrower claim than the marketing around cognitive health
typically makes, and it is considerably more actionable, because it identifies
exactly who should do something.


What changed on the access side

The practical barrier to acting on this shifted in 2022, when the Food and
Drug Administration established a regulatory category for over-the-counter
hearing aids, allowing adults with perceived mild to moderate hearing loss to
buy devices directly without a prescription, a medical exam, or a fitting
appointment. Prices fell substantially and the retail channel widened. The
change is not unqualified good news: self-fitting is genuinely harder than it
sounds, the devices suit a defined severity range and not beyond it, and
certain presentations should never be self-treated. Hearing loss in one ear
only, hearing loss accompanied by pain, drainage, dizziness or sudden onset, or
any rapid change in hearing requires medical evaluation rather than a purchase
— sudden sensorineural hearing loss in particular is a condition where
treatment delay measurably worsens the outcome. Within those limits, the option
that did not exist four years ago now does.


The Other Sense With the Same Shape

Hearing is not the only sensory channel with this pattern, and the parallel
case is instructive because it has the same structure and weaker evidence.

Vision impairment appears alongside hearing loss in the modifiable risk factor
literature, and observational work has reported that older adults who undergo
cataract surgery show lower subsequent rates of dementia diagnosis than those
with cataract who do not. The proposed mechanisms mirror the auditory ones:
degraded input, higher cognitive load, reduced engagement with the world
outside the house.

The evidentiary status differs in an important way. The cataract findings come
from cohort studies rather than randomized trials, and the confounding here is
severe: the people who proceed to elective surgery are systematically
healthier, better insured, and better connected to medical care than those who
do not. Some portion of the apparent benefit is almost certainly that
difference rather than the operation.

What makes the parallel worth drawing is not the strength of the second case.
It is that both sit in the same neglected category — corrections to sensory
input, in older adults, that are treated as conveniences rather than as
interventions with consequences beyond the sense involved. Whatever the
eventual verdict on cognition, restoring sight and restoring hearing are both
interventions whose immediate case is strong and whose uptake is poor for
reasons that have nothing to do with the evidence.


Why This Category Resists Attention

There is a structural reason hearing sits at the bottom of the health agenda
despite the evidence, and it is not that the information is unavailable.

Sensory decline is culturally coded as an inevitability rather than a
condition. Nobody expects to prevent it, nobody frames it as a target, and the
assistive device carries visible social meaning in a way that spectacles
stopped carrying decades ago. A person who would not hesitate to wear glasses
to read a menu will decline a hearing aid on grounds that are entirely about
how it looks.

The economics reinforce it. Hearing aids were, until recently, expensive and
inconsistently covered, and the acquisition process required multiple
appointments with a specialty most people have never visited. That combination
is a reliable recipe for deferral, and deferral in a slowly progressing
condition means the loss compounds while the decision is postponed.

And the benefit is diffuse where the cost is concrete. The cost is money,
time, and a visible device. The benefit is a slightly larger social world,
slightly less fatigue at the end of a day of listening, and — on the evidence
above, in the people at higher risk — a slower cognitive trajectory that no
individual will ever perceive as having happened.


The Version That Is Actually Actionable

Stripped to what a person can do, the list is short and none of it requires
believing anything about dementia.

A hearing test is quick, non-invasive, and available through audiologists,
many primary care practices, and increasingly through validated screening
tools. Anyone who has noticed that people mumble, that restaurants have become
difficult, or that the television volume has climbed has already produced the
indication for one.

If the loss is mild to moderate and the presentation is straightforward, the
over-the-counter category exists. If it is not straightforward — asymmetry,
sudden onset, accompanying symptoms — the correct first step is a clinician
rather than a retailer, and that distinction is the single most important
sentence in this piece.

The framing worth adopting is unglamorous. Hearing correction is not a
cognitive intervention. It is a quality-of-life intervention with a plausible
and partially demonstrated cognitive dividend in the people most at risk, and
the quality-of-life case alone is sufficient. Being able to follow a
conversation at a table of six is a good in itself, and it happens to be the
same action the strongest evidence supports.

The number to keep is not the halved decline in the subgroup. It is the years
of delay between noticing and acting, during which every mechanism proposed to
link the two conditions is running.


The bill, not the debate

Most attention on brain health goes to what is swallowed, and the commercial
category built on that assumption is enormous relative to the evidence behind
it. The intervention with randomized data attached is a device that corrects a
sense, and it reaches a minority of the people it applies to, years after they
first noticed. If conversations in restaurants have become work rather than
pleasure, how long has that been true, and what has anyone actually done about
it?Connor Hill reads every reply.


Sources checked: The Lancet — Hearing intervention versus health education
control to reduce cognitive decline in older adults with hearing loss in the
USA (ACHIEVE): a multicentre, randomised controlled trial, 2023
<[link removed](23)01406-X/abstract>
·PubMed Central — Cognitive benefits of hearing intervention vary by risk of
cognitive decline: A secondary analysis of the ACHIEVE trial
<[link removed]> · PubMed Central —
Recruitment and baseline data of the Aging and Cognitive Health Evaluation in
Elders (ACHIEVE) study <[link removed]> ·
Age and Ageing — Early detection and management of hearing loss to reduce
dementia risk in older adults with mild cognitive impairment: the TACT trial
<[link removed]> · U.S. Food and
Drug Administration — over-the-counter hearing aids regulatory category
<[link removed]>
·National Institute on Deafness and Other Communication Disorders — hearing
loss statistics and guidance
<[link removed]>


Connor Hill · InsightfulWord





You’re receiving this email from Insightful Word (IW), a brand of TerraTrance
Technologies, LLC.

Our mailing address: 200 Broadway Blvd NEAlbuquerque, NM 87102



Have a question or need assistance? Reply directly to this email or contact us
[email protected] <mailto:[email protected]>



The content of this email may not be copied, reproduced, forwarded, shared, or
distributed without the prior written consent of TerraTrance Technologies, LLC.

Privacy Policy <[link removed]>
Terms & Conditions <[link removed]>
Unsubscribe
<[link removed]>



© 2026 Insightful Word (IW). All Rights Reserved.